HIF1a or HIF2a: Enhancing CD8þ t-cell fitness for antitumor immunity

Abstract

Adoptive T-cell therapy requires the transferred lymphocytes to adapt to the hypoxic tumor microenvironment. In this issue, Veli¸ca and colleagues found that modified HIF2a expression in CD8þ T cells increases antitumor efficacy.